According to ImmunoGen 's latest financial reports the company's current revenue (TTM) is £0.21 B. In 2022 the company made a revenue of £89.91 M an increase over the revenue in the year 2021 that were of £51.61 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.